55 related articles for article (PubMed ID: 19580370)
1. Generation of immunogenic dendritic cells from human embryonic stem cells without serum and feeder cells.
Tseng SY; Nishimoto KP; Silk KM; Majumdar AS; Dawes GN; Waldmann H; Fairchild PJ; Lebkowski JS; Reddy A
Regen Med; 2009 Jul; 4(4):513-26. PubMed ID: 19580370
[TBL] [Abstract][Full Text] [Related]
2. An optimized cocktail of small molecule inhibitors promotes the maturation of dendritic cells in GM-CSF mouse bone marrow culture.
Matsuba S; Ura H; Saito F; Ogasawara C; Shimodaira S; Niida Y; Onai N
Front Immunol; 2023; 14():1264609. PubMed ID: 37901221
[TBL] [Abstract][Full Text] [Related]
3. Transcriptional dynamics of pluripotent stem cell-derived endothelial cell differentiation revealed by single-cell RNA sequencing.
McCracken IR; Taylor RS; Kok FO; de la Cuesta F; Dobie R; Henderson BEP; Mountford JC; Caudrillier A; Henderson NC; Ponting CP; Baker AH
Eur Heart J; 2020 Mar; 41(9):1024-1036. PubMed ID: 31242503
[TBL] [Abstract][Full Text] [Related]
4. Directed differentiation of human embryonic stem cells into parathyroid cells and establishment of parathyroid organoids.
Wang G; Du Y; Cui X; Xu T; Li H; Dong M; Li W; Li Y; Cai W; Xu J; Li S; Yang X; Wu Y; Chen H; Li X
Cell Prolif; 2024 Mar; ():e13634. PubMed ID: 38494923
[TBL] [Abstract][Full Text] [Related]
5. Adapting collagen/CNT matrix in directing hESC differentiation.
Sridharan I; Kim T; Wang R
Biochem Biophys Res Commun; 2009 Apr; 381(4):508-12. PubMed ID: 19233124
[TBL] [Abstract][Full Text] [Related]
6. Single-Cell RNA-seq Analysis of a Human Embryonic Stem Cell to Endothelial Cell System Based on Transcription Factor Overexpression.
Xu X; Chen J; Zhao H; Pi Y; Lin G; Hu L
Stem Cell Rev Rep; 2023 Oct; 19(7):2497-2509. PubMed ID: 37537495
[TBL] [Abstract][Full Text] [Related]
7. Glycopolymers With On/Off Anchors: Confinement Effect on Regulating Dendritic Cells.
Heng X; Shan F; Yang H; Hu J; Feng R; Tian W; Chen G; Chen H
Adv Healthc Mater; 2023 Nov; 12(28):e2301536. PubMed ID: 37590030
[TBL] [Abstract][Full Text] [Related]
8. Modification of human embryonic stem cell-derived dendritic cells with mRNA for efficient antigen presentation and enhanced potency.
Nishimoto KP; Tseng SY; Lebkowski JS; Reddy A
Regen Med; 2011 May; 6(3):303-18. PubMed ID: 21548736
[TBL] [Abstract][Full Text] [Related]
9. Dendritic cells and pluripotency: unlikely allies in the pursuit of immunotherapy.
Fairchild PJ; Leishman A; Sachamitr P; Telfer C; Hackett S; Davies TJ
Regen Med; 2015; 10(3):275-86. PubMed ID: 25933237
[TBL] [Abstract][Full Text] [Related]
10. Differentiation of dendritic cells from human embryonic stem cells.
Silk KM; Tseng SY; Nishimoto KP; Lebkowski J; Reddy A; Fairchild PJ
Methods Mol Biol; 2011; 767():449-61. PubMed ID: 21822895
[TBL] [Abstract][Full Text] [Related]
11. 'Off the shelf' immunotherapies: Generation and application of pluripotent stem cell-derived immune cells.
Wang C; Liu J; Li W
Cell Prolif; 2023 Apr; 56(4):e13425. PubMed ID: 36855955
[TBL] [Abstract][Full Text] [Related]
12. Differentiation of Human Induced Pluripotent Stem Cells (iPS Cells) and Embryonic Stem Cells (ES Cells) into Dendritic Cell (DC) Subsets.
Sontag S; Förster M; Seré K; Zenke M
Bio Protoc; 2017 Aug; 7(15):e2419. PubMed ID: 34541147
[TBL] [Abstract][Full Text] [Related]
13. Modeling Type 1 Diabetes Using Pluripotent Stem Cell Technology.
Joshi K; Cameron F; Tiwari S; Mannering SI; Elefanty AG; Stanley EG
Front Endocrinol (Lausanne); 2021; 12():635662. PubMed ID: 33868170
[TBL] [Abstract][Full Text] [Related]
14. The Immune-Modulatory Properties of iPSC-Derived Antigen-Presenting Cells.
Ackermann M; Dragon AC; Lachmann N
Transfus Med Hemother; 2020 Dec; 47(6):444-453. PubMed ID: 33442339
[TBL] [Abstract][Full Text] [Related]
15. Induction of macrophage-like immunosuppressive cells from common marmoset ES cells by stepwise differentiation with DZNep.
Tsuji H; Otsuka R; Wada H; Murata T; Sasaki A; Itoh M; Baghdadi M; Sasaki E; Seino KI
Sci Rep; 2020 Jul; 10(1):12625. PubMed ID: 32724084
[TBL] [Abstract][Full Text] [Related]
16. Artificial Antigen Presenting Cells: An Off the Shelf Approach for Generation of Desirable T-Cell Populations for Broad Application of Adoptive Immunotherapy.
Hasan AN; Selvakumar A; O'Reilly RJ
Adv Genet Eng; 2015; 4(3):. PubMed ID: 29644163
[TBL] [Abstract][Full Text] [Related]
17. Directed Differentiation of Human Induced Pluripotent Stem Cells into Dendritic Cells Displaying Tolerogenic Properties and Resembling the CD141
Sachamitr P; Leishman AJ; Davies TJ; Fairchild PJ
Front Immunol; 2017; 8():1935. PubMed ID: 29358940
[TBL] [Abstract][Full Text] [Related]
18. Inherent Immunogenicity or Lack Thereof of Pluripotent Stem Cells: Implications for Cell Replacement Therapy.
Chhabra A
Front Immunol; 2017; 8():993. PubMed ID: 28868053
[TBL] [Abstract][Full Text] [Related]
19. Harnessing the properties of dendritic cells in the pursuit of immunological tolerance.
Horton C; Shanmugarajah K; Fairchild PJ
Biomed J; 2017 Apr; 40(2):80-93. PubMed ID: 28521905
[TBL] [Abstract][Full Text] [Related]
20. Antigenically Modified Human Pluripotent Stem Cells Generate Antigen-Presenting Dendritic Cells.
Zeng J; Wu C; Wang S
Sci Rep; 2015 Oct; 5():15262. PubMed ID: 26471005
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
